ヘパリン API市場調査レポート 2025年

世界のヘパリン API市場は2024年に12億3,000万米ドルと評価され、2025年から2031年の予測期間中に7.77%のCAGRで成長し、2031年までに23億米ドルに達すると予想されています。

このレポートは、ヘパリン API メーカー、新規参入企業、およびこの市場の業界チェーン関連企業に、市場全体とサブセグメントのさまざまなセグメント、企業別、タイプ別、アプリケーション別、地域別の収益、販売量、平均価格に関する情報を提供します。

Report Overview

The global Heparin API market was valued at US$ 1.23 billion in 2024 and is anticipated to reach US$ 2.30 billion by 2031, witnessing a CAGR of 7.77% during the forecast period 2025-2031.

North American market for Heparin API is estimated to increase from $ 431.49 million in 2025 to reach $ 671.33 million by 2031, at a CAGR of 7.65% during the forecast period of 2025 through 2031.

Asia-Pacific market for Heparin API is estimated to increase from $ 478.50 million in 2025 to reach $ 799.46 million by 2031, at a CAGR of 8.93% during the forecast period of 2025 through 2031.

Europe market for Heparin API is estimated to increase from $ 537.57 million in 2025 to reach $ 801.22 million by 2031, at a CAGR of 6.88% during the forecast period of 2025 through 2031.

The major global manufacturers of Heparin API include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc. In 2024, the world’s top three vendors accounted for approximately 38% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Heparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin API.

The Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Heparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

•                 Shenzhen Hepalink Pharmaceutical
•                 Yantai Dongcheng Pharmaceutical
•                 Pfizer
•                 Bioibérica
•                 Changzhou Qianhong Biopharma
•                 Nanjing King-friend Biochemical Pharmaceutical
•                 Hebei Changshan Biochemical Pharmaceutical
•                 Qingdao Jiulong Biopharmaceutical
•                 Opocrin
•                 Dongying Tiandong Pharmaceutical
•                 Aspen Oss
•                 Yino Pharma
•                 Nanjing Xinbai Pharmaceutical
•                 Hubei Enoray Biopharmaceutical
•                 Cisen Pharmaceutical

Segment by Type

•                 Heparin Sodium API
•                 Heparin Calcium API

Segment by Application

•                 UFH
•                 LMWH

Consumption by Region

North America

•                 United States
•                 Canada

Asia-Pacific

•                 China
•                 Japan
•                 India
•                 Rest of APAC

Europe

•                 Germany
•                 France
•                 U.K.
•                 Italy
•                 Spain
•                 Rest of Europe

Latin America

•                 Mexico
•                 Brazil
•                 Rest of Latin America

Middle East & Africa

•                 Middle East
•                 Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Heparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Heparin API Market Overview       1

1.1 Product Definition         1

1.2 Heparin API by Type    1

1.2.1 Global Heparin API Market Value Comparison by Type (2024 VS 2031)      1

1.2.2 Heparin Sodium API 3

1.2.3 Heparin Calcium API 3

1.3 Heparin API by Application         4

1.3.1 Global Heparin API Market Value by Application (2024 VS 2031)                 4

1.3.2 UFH              6

1.3.3 LMWH         6

1.4 Global Heparin API Market Size Estimates and Forecasts     7

1.4.1 Global Heparin API Revenue 2020-2031                7

1.4.2 Global Heparin API Sales 2020-2031      8

1.4.3 Global Heparin API Market Average Price (2020-2031)     9

1.5 Assumptions and Limitations       9

2 Heparin API Market Competition by Manufacturers 12

2.1 Global Heparin API Sales Market Share by Manufacturers (2020-2025)      12

2.2 Global Heparin API Revenue Market Share by Manufacturers (2020-2025)      14

2.3 Global Heparin API Average Price by Manufacturers (2020-2025)                 16

2.4 Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024  16

2.5 Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters         17

2.6 Global Key Manufacturers of Heparin API, Product Type     18

2.7 Global Key Manufacturers of Heparin API, Founded Date    18

2.8 Global Heparin API Market Competitive Situation and Trends                 19

2.8.1 Global Heparin API Market Concentration Rate  19

2.8.2 The Global 5 and 10 Largest Heparin API Players Market Share by Revenue 20

2.8.3 Global Heparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)       20

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans      22

3 Global Heparin API Market Scenario by Region          23

3.1 Global Heparin API Market Size by Region: 2020 Versus 2024 Versus 2031        23

3.2 Global Heparin API Sales by Region: 2020-2031      24

3.2.1 Global Heparin API Sales by Region: 2020-2025  24

3.2.2 Global Heparin API Sales by Region: 2026-2031  25

3.3 Global Heparin API Revenue by Region: 2020-2031                25

3.3.1 Global Heparin API Revenue by Region: 2020-2025            25

3.3.2 Global Heparin API Revenue by Region: 2026-2031            26

3.4 North America Heparin API Market Facts & Figures by Country                 27

3.4.1 North America Heparin API Market Size by Country: 2020 VS 2024 VS 2031  27

3.4.2 North America Heparin API Sales by Country (2020-2031)                 27

3.4.3 North America Heparin API Revenue by Country (2020-2031)                 27

3.4.4 United States               28

3.4.5 Canada          29

3.5 Europe Heparin API Market Facts & Figures by Country       29

3.5.1 Europe Heparin API Market Size by Country: 2020 VS 2024 VS 2031                 29

3.5.2 Europe Heparin API Sales by Country (2020-2031)             30

3.5.3 Europe Heparin API Revenue by Country (2020-2031)       30

3.5.4 Germany      31

3.5.5 France           32

3.5.6 U.K.               32

3.5.7 Italy               33

3.5.8 Spain             33

3.6 Asia Pacific Heparin API Market Facts & Figures by Region 34

3.6.1 Asia Pacific Heparin API Market Size by Region: 2020 VS 2024 VS 2031        34

3.6.2 Asia Pacific Heparin API Sales by Region (2020-2031)       34

3.6.3 Asia Pacific Heparin API Revenue by Region (2020-2031)                 35

3.6.4 China            35

3.6.5 Japan             36

3.6.6 India              36

3.7 Latin America Heparin API Market Facts & Figures by Country                 37

3.7.1 Latin America Heparin API Market Size by Country: 2020 VS 2024 VS 2031  37

3.7.2 Latin America Heparin API Sales by Country (2020-2031)                 37

3.7.3 Latin America Heparin API Revenue by Country (2020-2031)                 37

3.7.4 Mexico          38

3.7.5 Brazil            39

3.8 Middle East and Africa Heparin API Market Facts & Figures by Country  39

3.8.1 Middle East and Africa Heparin API Market Size by Country: 2020 VS 2024 VS 2031  39

3.8.2 Middle East and Africa Heparin API Sales by Country (2020-2031)                 40

3.8.3 Middle East and Africa Heparin API Revenue by Country (2020-2031)      40

3.8.4 Middle East 41

3.8.5 Africa            41

4 Segment by Type               42

4.1 Global Heparin API Sales by Type (2020-2031)       42

4.1.1 Global Heparin API Sales by Type (2020-2025)   42

4.1.2 Global Heparin API Sales by Type (2026-2031)   42

4.1.3 Global Heparin API Sales Market Share by Type (2020-2031)                 42

4.2 Global Heparin API Revenue by Type (2020-2031)                 43

4.2.1 Global Heparin API Revenue by Type (2020-2025)             43

4.2.2 Global Heparin API Revenue by Type (2026-2031)             43

4.2.3 Global Heparin API Revenue Market Share by Type (2020-2031)                 44

4.3 Global Heparin API Price by Type (2020-2031)      45

Segment by Application      46

4.4 Global Heparin API Sales by Application (2020-2031)            46

4.4.1 Global Heparin API Sales by Application (2020-2025)        46

4.4.2 Global Heparin API Sales by Application (2026-2031)        46

4.4.3 Global Heparin API Sales Market Share by Application (2020-2031)                 46

4.5 Global Heparin API Revenue by Application (2020-2031)     47

4.5.1 Global Heparin API Revenue by Application (2020-2025)  47

4.5.2 Global Heparin API Revenue by Application (2026-2031)  47

4.5.3 Global Heparin API Revenue Market Share by Application (2020-2031)      48

4.6 Global Heparin API Price by Application (2020-2031)           49

5 Key Company Profiled     50

5.1 Shenzhen Hepalink Pharmaceutical            50

5.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information                 50

5.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview                50

5.1.3 Shenzhen Hepalink Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025) 51

5.1.4 Shenzhen Hepalink Pharmaceutical Heparin API Products Offered                 51

5.2 Yantai Dongcheng Pharmaceutical             52

5.2.1 Yantai Dongcheng Pharmaceutical Corporation Information                 52

5.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview                53

5.2.3 Yantai Dongcheng Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025) 53

5.2.4 Yantai Dongcheng Pharmaceutical Heparin API Products Offered                 54

5.3 Pfizer                55

5.3.1 Pfizer Corporation Information                55

5.3.2 Pfizer Introduction and Business Overview            56

5.3.3 Pfizer Heparin API Sales, Revenue and Gross Margin (2020-2025)                 56

5.3.4 Pfizer Heparin API Products Offered     56

5.4 Bioibérica        57

5.4.1 Bioibérica Corporation Information        57

5.4.2 Bioibérica Introduction and Business Overview    58

5.4.3 Bioibérica Heparin API Sales, Revenue and Gross Margin (2020-2025)      58

5.4.4 Bioibérica Heparin API Products Offered              58

5.5 Changzhou Qianhong Biopharma               60

5.5.1 Changzhou Qianhong Biopharma Corporation Information                 60

5.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview                61

5.5.3 Changzhou Qianhong Biopharma Heparin API Sales, Revenue and Gross Margin (2020-2025) 61

5.5.4 Changzhou Qianhong Biopharma Heparin API Products Offered                 62

5.6 Nanjing King-friend Biochemical Pharmaceutical   63

5.6.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information            63

5.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview                63

5.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)          64

5.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Products Offered  64

5.7 Hebei Changshan Biochemical Pharmaceutical        65

5.7.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information            65

5.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview                65

5.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)          66

5.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Products Offered  66

5.8 Qingdao Jiulong Biopharmaceutical           67

5.8.1 Qingdao Jiulong Biopharmaceutical Corporation Information                 67

5.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview                68

5.8.3 Qingdao Jiulong Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025) 68

5.8.4 Qingdao Jiulong Biopharmaceutical Heparin API Products Offered                 69

5.9 Opocrin           70

5.9.1 Opocrin Corporation Information            70

5.9.2 Opocrin Introduction and Business Overview       71

5.9.3 Opocrin Heparin API Sales, Revenue and Gross Margin (2020-2025)                 71

5.9.4 Opocrin Heparin API Products Offered 71

5.10 Dongying Tiandong Pharmaceutical        72

5.10.1 Dongying Tiandong Pharmaceutical Corporation Information                 72

5.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview                73

5.10.3 Dongying Tiandong Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)          73

5.10.4 Dongying Tiandong Pharmaceutical Heparin API Products Offered                 74

5.11 Aspen Oss     75

5.11.1 Aspen Oss Corporation Information     75

5.11.2 Aspen Oss Introduction and Business Overview 75

5.11.3 Aspen Oss Heparin API Sales, Revenue and Gross Margin (2020-2025)      76

5.11.4 Aspen Oss Heparin API Products Offered           76

5.12 Yino Pharma 77

5.12.1 Yino Pharma Corporation Information 77

5.12.2 Yino Pharma Introduction and Business Overview             77

5.12.3 Yino Pharma Heparin API Sales, Revenue and Gross Margin (2020-2025)      78

5.12.4 Yino Pharma Heparin API Products Offered      78

5.13 Nanjing Xinbai Pharmaceutical 78

5.13.1 Nanjing Xinbai Pharmaceutical Corporation Information 78

5.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview                79

5.13.3 Nanjing Xinbai Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025) 79

5.13.4 Nanjing Xinbai Pharmaceutical Heparin API Products Offered                 80

5.14 Hubei Enoray Biopharmaceutical              80

5.14.1 Hubei Enoray Biopharmaceutical Corporation Information                 80

5.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview                81

5.14.3 Hubei Enoray Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025) 81

5.14.4 Hubei Enoray Biopharmaceutical Heparin API Products Offered                 82

5.15 Cisen Pharmaceutical 82

5.15.1 Cisen Pharmaceutical Corporation Information 82

5.15.2 Cisen Pharmaceutical Introduction and Business Overview                 83

5.15.3 Cisen Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)             83

5.15.4 Cisen Pharmaceutical Heparin API Products Offered       84

6 Industry Chain and Sales Channels Analysis                 86

6.1 Heparin API Industry Chain Analysis        86

6.2 Heparin API Raw Material Supply Analysis               86

6.2.1 Key Raw Materials      87

6.2.2 Raw Materials Key Suppliers    88

6.3 Heparin API Production Mode & Process Analysis 89

6.4 Heparin API Sales and Marketing               90

6.4.1 Heparin API Sales Channels     90

6.4.2 Heparin API Distributors          92

6.5 Heparin API Customer Analysis 92

7 Heparin API Market Dynamics      94

7.1 Heparin API Industry Trends      94

7.2 Heparin API Market Drivers        95

7.3 Heparin API Market Challenges 96

7.4 Heparin API Market Restraints   97

8 Research Findings and Conclusion 98

9 Methodology and Data Source        100

9.1 Methodology/Research Approach               100

9.1.1 Research Programs/Design      100

9.1.2 Market Size Estimation              101

9.1.3 Market Breakdown and Data Triangulation           102

9.2 Data Source    103

9.2.1 Secondary Sources      103

9.2.2 Primary Sources          104

9.3 Author Details                106

9.4 Disclaimer       107

Tables and Figures

Table 1. Global Heparin API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)        1

Table 2. Global Heparin API Market Value by Application (2024 VS 2031) & (US$ Million)   4

Table 3. Global Heparin API Market Competitive Situation by Manufacturers in 2024         12

Table 4. Global Heparin API Sales (Billion Units) of Key Manufacturers (2020-2025)           13

Table 5. Global Heparin API Sales Market Share by Manufacturers (2020-2025)      13

Table 6. Global Heparin API Revenue (US$ Million) by Manufacturers (2020-2025)           14

Table 7. Global Heparin API Revenue Share by Manufacturers (2020-2025)      15

Table 8. Global Market Heparin API Average Price (US$/Billion Units) of Key Manufacturers (2020-2025)   16

Table 9. Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024        16

Table 10. Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters    17

Table 11. Global Key Manufacturers of Heparin API, Product Type                 18

Table 12. Global Key Manufacturers of Heparin API, Founded Date                 18

Table 13. Global Manufacturers Market Concentration Ratio (CR5)                 19

Table 14. Global Heparin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin API as of 2024)               20

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans                 22

Table 16. Global Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031  23

Table 17. Global Heparin API Sales by Region (2020-2025) & (Billion Units)     24

Table 18. Global Heparin API Sales Market Share by Region (2020-2025)                 24

Table 19. Global Heparin API Sales by Region (2026-2031) & (Billion Units)     25

Table 20. Global Heparin API Sales Market Share by Region (2026-2031)                 25

Table 21. Global Heparin API Revenue by Region (2020-2025) & (US$ Million)        25

Table 22. Global Heparin API Revenue Market Share by Region (2020-2025)      26

Table 23. Global Heparin API Revenue by Region (2026-2031) & (US$ Million)        26

Table 24. Global Heparin API Revenue Market Share by Region (2026-2031)      26

Table 25. North America Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)        27

Table 26. North America Heparin API Sales by Country (2020-2025) & (Billion Units)      27

Table 27. North America Heparin API Sales by Country (2026-2031) & (Billion Units)      27

Table 28. North America Heparin API Revenue by Country (2020-2025) & (US$ Million)   27

Table 29. North America Heparin API Revenue by Country (2026-2031) & (US$ Million)   28

Table 30. Europe Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)              29

Table 31. Europe Heparin API Sales by Country (2020-2025) & (Billion Units)     30

Table 32. Europe Heparin API Sales by Country (2026-2031) & (Billion Units)     30

Table 33. Europe Heparin API Revenue by Country (2020-2025) & (US$ Million)        30

Table 34. Europe Heparin API Revenue by Country (2026-2031) & (US$ Million)        31

Table 35. Asia Pacific Heparin API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)              34

Table 36. Asia Pacific Heparin API Sales by Region (2020-2025) & (Billion Units)     34

Table 37. Asia Pacific Heparin API Sales by Region (2026-2031) & (Billion Units)     34

Table 38. Asia Pacific Heparin API Revenue by Region (2020-2025) & (US$ Million)        35

Table 39. Asia Pacific Heparin API Revenue by Region (2026-2031) & (US$ Million)        35

Table 40. Latin America Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)        37

Table 41. Latin America Heparin API Sales by Country (2020-2025) & (Billion Units)      37

Table 42. Latin America Heparin API Sales by Country (2026-2031) & (Billion Units)      37

Table 43. Latin America Heparin API Revenue by Country (2020-2025) & (US$ Million)   37

Table 44. Latin America Heparin API Revenue by Country (2026-2031) & (US$ Million)   38

Table 45. Middle East and Africa Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)        39

Table 46. Middle East and Africa Heparin API Sales by Country (2020-2025) & (Billion Units)       40

Table 47. Middle East and Africa Heparin API Sales by Country (2026-2031) & (Billion Units)       40

Table 48. Middle East and Africa Heparin API Revenue by Country (2020-2025) & (US$ Million)        40

Table 49. Middle East and Africa Heparin API Revenue by Country (2026-2031) & (US$ Million)        40

Table 50. Global Heparin API Sales (Billion Units) by Type (2020-2025)                 42

Table 51. Global Heparin API Sales (Billion Units) by Type (2026-2031)                 42

Table 52. Global Heparin API Sales Market Share by Type (2020-2025)                 42

Table 53. Global Heparin API Sales Market Share by Type (2026-2031)                 42

Table 54. Global Heparin API Revenue (US$ Million) by Type (2020-2025)      43

Table 55. Global Heparin API Revenue (US$ Million) by Type (2026-2031)      43

Table 56. Global Heparin API Revenue Market Share by Type (2020-2025)      44

Table 57. Global Heparin API Revenue Market Share by Type (2026-2031)      44

Table 58. Global Heparin API Price (US$/Billion Units) by Type (2020-2025)      45

Table 59. Global Heparin API Price (US$/Billion Units) by Type (2026-2031)      45

Table 60. Global Heparin API Sales (Billion Units) by Application (2020-2025)      46

Table 61. Global Heparin API Sales (Billion Units) by Application (2026-2031)      46

Table 62. Global Heparin API Sales Market Share by Application (2020-2025)      46

Table 63. Global Heparin API Sales Market Share by Application (2026-2031)      46

Table 64. Global Heparin API Revenue (US$ Million) by Application (2020-2025)           47

Table 65. Global Heparin API Revenue (US$ Million) by Application (2026-2031)           47

Table 66. Global Heparin API Revenue Market Share by Application (2020-2025)           48

Table 67. Global Heparin API Revenue Market Share by Application (2026-2031)           48

Table 68. Global Heparin API Price (US$/Billion Units) by Application (2020-2025)           49

Table 69. Global Heparin API Price (US$/Billion Units) by Application (2026-2031)           49

Table 70. Shenzhen Hepalink Pharmaceutical Corporation Information                 50

Table 71. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview                50

Table 72. Shenzhen Hepalink Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)             51

Table 73. Shenzhen Hepalink Pharmaceutical Heparin API Product                 51

Table 74. Yantai Dongcheng Pharmaceutical Corporation Information                 52

Table 75. Yantai Dongcheng Pharmaceutical Introduction and Business Overview                53

Table 76. Yantai Dongcheng Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)             53

Table 77. Yantai Dongcheng Pharmaceutical Heparin API Product                 54

Table 78. Pfizer Corporation Information        55

Table 79. Pfizer Introduction and Business Overview   56

Table 80. Pfizer Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)            56

Table 81. Pfizer Heparin API Product              56

Table 82. Bioibérica Corporation Information                 57

Table 83. Bioibérica Introduction and Business Overview            58

Table 84. Bioibérica Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)                 58

Table 85. Bioibérica Heparin API Product      58

Table 86. Changzhou Qianhong Biopharma Corporation Information                 60

Table 87. Changzhou Qianhong Biopharma Introduction and Business Overview                61

Table 88. Changzhou Qianhong Biopharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)             61

Table 89. Changzhou Qianhong Biopharma Heparin API Product                 62

Table 90. Nanjing King-friend Biochemical Pharmaceutical Corporation Information            63

Table 91. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview        63

Table 92. Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)          64

Table 93. Nanjing King-friend Biochemical Pharmaceutical Heparin API Product  64

Table 94. Hebei Changshan Biochemical Pharmaceutical Corporation Information            65

Table 95. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview                65

Table 96. Hebei Changshan Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)          66

Table 97. Hebei Changshan Biochemical Pharmaceutical Heparin API Product  66

Table 98. Qingdao Jiulong Biopharmaceutical Corporation Information                 67

Table 99. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview                68

Table 100. Qingdao Jiulong Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)             68

Table 101. Qingdao Jiulong Biopharmaceutical Heparin API Product                 69

Table 102. Opocrin Corporation Information 70

Table 103. Opocrin Introduction and Business Overview             71

Table 104. Opocrin Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)                 71

Table 105. Opocrin Heparin API Product       71

Table 106. Dongying Tiandong Pharmaceutical Corporation Information                 72

Table 107. Dongying Tiandong Pharmaceutical Introduction and Business Overview                73

Table 108. Dongying Tiandong Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025) 73

Table 109. Dongying Tiandong Pharmaceutical Heparin API Product                 74

Table 110. Aspen Oss Corporation Information              75

Table 111. Aspen Oss Introduction and Business Overview         75

Table 112. Aspen Oss Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)                 76

Table 113. Aspen Oss Heparin API Product   76

Table 114. Yino Pharma Corporation Information         77

Table 115. Yino Pharma Introduction and Business Overview     77

Table 116. Yino Pharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)                 78

Table 117. Yino Pharma Heparin API Product               78

Table 118. Nanjing Xinbai Pharmaceutical Corporation Information                 78

Table 119. Nanjing Xinbai Pharmaceutical Introduction and Business Overview                79

Table 120. Nanjing Xinbai Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)             79

Table 121. Nanjing Xinbai Pharmaceutical Heparin API Product                 80

Table 122. Hubei Enoray Biopharmaceutical Corporation Information                 80

Table 123. Hubei Enoray Biopharmaceutical Introduction and Business Overview                81

Table 124. Hubei Enoray Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)             81

Table 125. Hubei Enoray Biopharmaceutical Heparin API Product                 82

Table 126. Cisen Pharmaceutical Corporation Information          82

Table 127. Cisen Pharmaceutical Introduction and Business Overview                 83

Table 128. Cisen Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)           83

Table 129. Cisen Pharmaceutical Heparin API Product                84

Table 130. Key Raw Materials Lists  87

Table 131. Raw Materials Key Suppliers Lists 88

Table 132. Heparin API Distributors List        92

Table 133. Heparin API Customers List           92

Table 134. Heparin API Market Trends           94

Table 135. Heparin API Market Drivers          95

Table 136. Heparin API Market Challenges    96

Table 137. Heparin API Market Restraints      97

Table 138. Research Programs/Design for This Report                 100

Table 139. Key Data Information from Secondary Sources           104

Table 140. Key Data Information from Primary Sources               105

List of Figures

Figure 1. Product Picture of Heparin API       1

Figure 2. Global Heparin API Market Value Comparison by Type (2020-2031) & (US$ Million)        2

Figure 3. Global Heparin API Revenue Market Share by Type: 2024 & 2031        2

Figure 4. Heparin Sodium API Product Picture              3

Figure 5. Heparin Calcium API Product Picture             4

Figure 6. Global Heparin API Market Value by Application (2020-2031) & (US$ Million)   5

Figure 7. Global Heparin API Revenue Market Share by Application: 2024 & 2031    5

Figure 8. UFH       6

Figure 9. LMWH  6

Figure 10. Global Heparin API Revenue, (US$ Million), 2020 VS 2024 VS 2031        7

Figure 11. Global Heparin API Market Size (2020-2031) & (US$ Million)                 8

Figure 12. Global Heparin API Sales (2020-2031) & (Billion Units)                 8

Figure 13. Global Heparin API Average Price (US$/Billion Units) & (2020-2031)           9

Figure 14. Heparin API Report Years Considered          10

Figure 15. Global 5 and 10 Largest Heparin API Players: Market Share by Revenue in Heparin API in 2024       20

Figure 16. Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): in 2024             21

Figure 17. Global Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031  24

Figure 18. United States Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)   28

Figure 19. Canada Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        29

Figure 20. Germany Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        31

Figure 21. France Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        32

Figure 22. U.K. Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        32

Figure 23. Italy Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        33

Figure 24. Spain Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        33

Figure 25. China Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        35

Figure 26. Japan Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        36

Figure 27. India Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        36

Figure 28. Mexico Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        38

Figure 29. Brazil Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        39

Figure 30. Middle East Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)   41

Figure 31. Africa Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)        41

Figure 32. Global Sales Market Share of Heparin API by Type (2020-2031)                 43

Figure 33. Global Revenue Market Share of Heparin API by Type (2020-2031)      44

Figure 34. Global Sales Market Share of Heparin API by Application (2020-2031)           47

Figure 35. Global Revenue Market Share of Heparin API by Application (2020-2031)           48

Figure 36. Heparin API Value Chain                 86

Figure 37. Number of Pigs Worldwide from 2012 to 2025 (in million head)                 87

Figure 38. Number of Pigs Worldwide in 2025, by Leading Country (in million head)         88

Figure 39. Heparin API Production Process   89

Figure 40. Channels of Distribution 91

Figure 41. Bottom-up and Top-down Approaches for This Report                 102

Figure 42. Data Triangulation            103

Figure 43. Key Executives Interviewed              105

QYResearchは広範な市場を対象にし、多様な市場調査レポートを出版している中国北京に本社をおく市場調査会社です。QYResearch出版の市場調査レポートに関するご質問やサンプルページのご依頼等はいつでもお気軽にお問合せください。

QYResearch 出版レポート一覧

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイル閲覧可のライセンスです。
    • 提供ファイルはPDFファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
  • マルチユーザライセンス
    • 同一企業内10名までレポートファイルの閲覧可のライセンスです。
    • 提供ファイルはPDFとExcelファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
  • エンタープライズライセンス
    • 同一企業および関連会社内において人数無制限でレポートファイルの閲覧可のライセンスです。
    • 提供ファイルはPDFとExcelファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
• 納期
  • 既刊レポート：ご注文後3営業日以内
  • オンデマンドレポート：通常7営業日前後

• 納品形態
  • Eメール

注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでのご注文をお待ちしております。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。